Biogen, Inc. (NQ: BIIB )
270.12 USD -0.16 (-0.06%) Official Closing Price Updated: 6:37 PM EST, Jan 21, 2021 Add to My Watchlist
Stories about Biogen, Inc.
Biogen Loses Patent Case Over Its Best-Selling Drug
June 18, 2020
The S&P 500 closed nominally higher on Thursday as investors weighed a resurgence in coronavirus infections and the possibility of a new round of shutdowns as well as data that suggested the U.S....
Why Biogen's Stock Is Trading Lower Today
June 18, 2020
Biogen Inc (NASDAQ: BIIB) shares are trading lower on Thursday following reports the company has lost a patent dispute against Mylan for ...
Big shares of a losing biotech stock didn’t stop a pair of four-star-rated ETFs from moving higher Thursday. They may sound similar, but hold distinct investments once you look under the hood.
* Indexes mixed: Dow dips 0.52%, S&P off 0.27%, Nasdaq flat (Updates to late afternoon, changes dateline, byline)
Biogen stock plunged Thursday after a West Virginia judge reportedly invalidated a patent protecting its multiple sclerosis blockbuster drug, Tecfidera, against a Mylan knockoff.
Morning Market Stats in 5 Minutes
June 18, 2020
Movers Indices • S&P 500 ETF (NYSE:SPY) decreased 0.56% to $309.82. • Nasdaq ETF (NASDAQ:QQQ) fell 0.14% to ...
Biogen is joining the hunt for a coronavirus treatment with Vir Biotechnology. Further, the company is working on an Alzheimer's drug. So, is now the time to buy Biogen stock?
Better Buy: Gilead Sciences vs. Biogen
June 18, 2020
One of these pharmaceutical giants has the only reasonably effective treatment so far for COVID-19, while the other has high hopes for its Alzheimer's disease drug candidate.
Here are the best and worst stocks during the first 100 days of the coronavirus pandemic
June 17, 2020
Notable Tuesday Option Activity: BIIB, KR, HRB
June 16, 2020
Looking at options trading activity among components of the Russell 3000 index, there is noteworthy activity today in Biogen Inc (BIIB), where a total volume of 6,360 contracts has been traded thus far...
Implied MOAT Analyst Target Price: $58
June 15, 2020
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and...
Better Buy: CRISPR Therapeutics vs. Sangamo Therapeutics
June 14, 2020
IBB, VRTX, BIIB, ILMN: Large Outflows Detected at ETF
June 12, 2020
Symbols mentioned in this story: IBB, VRTX, BIIB, ILMN Exchange traded funds (ETFs) trade just like stocks, but instead of ''shares'' investors are actually buying and selling ''units''. These...
BIIB Makes Notable Cross Below Critical Moving Average
June 11, 2020
In trading on Thursday, shares of Biogen Inc (BIIB) crossed below their 200 day moving average of $287.39, changing hands as low as $281.20 per share. Biogen Inc shares are currently trading down about...
Should You Sell Biogen Stock?
June 10, 2020
With the biotech facing two issues each that could result in major headwinds, a Bernstein analyst has downgraded its stock.
Benzinga's Top Upgrades, Downgrades For June 9, 2020
June 09, 2020
Upgrades B of A Securities upgraded the stock forOccidental Petroleum Corp(NYSE: OXY) from Neutral to Buy. Occidental ...
The weekend was abuzz with rumors of U.K. pharma giant AstraZeneca plc's (NYSE: AZN) reported interest in U.S.-based large-cap ...
Noteworthy Monday Option Activity: NAT, ZGNX, BIIB
June 08, 2020
Among the underlying components of the Russell 3000 index, we saw noteworthy options trading volume today in Nordic American Tankers Ltd (NAT), where a total of 40,927 contracts have traded so far,...
The company is an aggressive newcomer to the infectious-disease market and its COVID-19 programs are very promising.
Better Buy: Biogen vs. Axsome Therapeutics
May 23, 2020
One biotech has been big long-time winner, the other is a promising up-and-comer with no revenue -- yet. But picking an investment is always a bet on the future.
Noteworthy ETF Outflows: IVE, IBM, FIS, BIIB
May 22, 2020
Symbols mentioned in this story: IVE, IBM, FIS, BIIB Exchange traded funds (ETFs) trade just like stocks, but instead of ''shares'' investors are actually buying and selling ''units''. These ''units''...
Hedge funds have relied on technology, internet, media and telecom companies and increasingly more health care companies to drive performance.